Synopsis
0
USDMF
0
CEP/COS
0
NDC API
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
65
PharmaCompass offers a list of Camostat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Camostat manufacturer or Camostat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Camostat manufacturer or Camostat supplier.
PharmaCompass also assists you with knowing the Camostat API Price utilized in the formulation of products. Camostat API Price is not always fixed or binding as the Camostat Price is obtained through a variety of data sources. The Camostat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Camostat mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Camostat mesylate, including repackagers and relabelers. The FDA regulates Camostat mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Camostat mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Camostat mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Camostat mesylate supplier is an individual or a company that provides Camostat mesylate active pharmaceutical ingredient (API) or Camostat mesylate finished formulations upon request. The Camostat mesylate suppliers may include Camostat mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Camostat mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Camostat mesylate Drug Master File in Japan (Camostat mesylate JDMF) empowers Camostat mesylate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Camostat mesylate JDMF during the approval evaluation for pharmaceutical products. At the time of Camostat mesylate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Camostat mesylate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Camostat mesylate Drug Master File in Korea (Camostat mesylate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Camostat mesylate. The MFDS reviews the Camostat mesylate KDMF as part of the drug registration process and uses the information provided in the Camostat mesylate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Camostat mesylate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Camostat mesylate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Camostat mesylate suppliers with KDMF on PharmaCompass.
A Camostat mesylate written confirmation (Camostat mesylate WC) is an official document issued by a regulatory agency to a Camostat mesylate manufacturer, verifying that the manufacturing facility of a Camostat mesylate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Camostat mesylate APIs or Camostat mesylate finished pharmaceutical products to another nation, regulatory agencies frequently require a Camostat mesylate WC (written confirmation) as part of the regulatory process.
click here to find a list of Camostat mesylate suppliers with Written Confirmation (WC) on PharmaCompass.
Camostat mesylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Camostat mesylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Camostat mesylate GMP manufacturer or Camostat mesylate GMP API supplier for your needs.
A Camostat mesylate CoA (Certificate of Analysis) is a formal document that attests to Camostat mesylate's compliance with Camostat mesylate specifications and serves as a tool for batch-level quality control.
Camostat mesylate CoA mostly includes findings from lab analyses of a specific batch. For each Camostat mesylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Camostat mesylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Camostat mesylate EP), Camostat mesylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Camostat mesylate USP).
